Despite advances in screening, diagnosis, and treatment for prostate cancer (PCa), Black men tend to be diagnosed at younger ages, have higher mortality rates, and are at increased risk of recurrence or metastasis compared to their White counterparts. PCa disparities among Black men are caused by a complex interaction of social, behavioral, and biological factors across the public policy, community, organizational, interpersonal, and individual levels. Key contributing factors include mistrust in the health care system, poor communication between patients and providers, low awareness of screening guidelines, and high medical costs. These disparities are further exacerbated by the low representation of Black men in clinical trials, which limits access to high-quality cancer care and generalizability for PCa treatments. In this narrative review of the existing literature, we examined the epidemiology and identified contributing factors, and propose multi-level strategies to address and mitigate disparities among Black men with PCa.
Cancer control : journal of the Moffitt Cancer Center. 2024 Dec [Epub]
Anastasia Murphy, Cherell C Cottrell-Daniels, Shivanshu Awasthi, Esther Katende, Jong Y Park, Justin Denis, B Lee Green, Kosj Yamoah
Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA., Research Department, Health Choice Network Inc, Miami, FL, USA., Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.